Zdrowie i gospodarka · 15/01/2021
FDA Publishes Transparency on Drug Review Timeline Policy
The US Food and Drug Administration (FDA) has released a statement outlining its policy on transparency regarding the review timeline for new drug submissions, aiming to increase public awareness and trust in the agency's decision-making process.